Exscientia inks strategic drug discovery collaboration with GSK
Exscientia Ltd. entered into a drug discovery collaboration with GlaxoSmithKline PLC in which it agreed to apply its AI platform to discover novel selective small molecules with GSK for up to 10 disease-related targets.
- Digital Health
- Drug Discovery Tools
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com